Patents by Inventor David N. Deaton

David N. Deaton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrolidines as dipeptidyl peptidase inhibitors
    Patent number: 7196201
    Abstract: The present invention relates to novel compounds, their use for inhibiting serine proteases, such as dipeptidyl peptidases, such as dipeptidyl peptidase IV (DPP-IV) and to methods for their production and their therapeutic utility
    Type: Grant
    Filed: June 26, 2002
    Date of Patent: March 27, 2007
    Assignee: SmithKline Beecham Corporation
    Inventors: Curt Dale Haffner, Darryl Lynn McDougald, Amarjit Sab Randhawa, Steven Michael Reister, David N Deaton
  • Phenethanolamine derivatives, compositions, and their use as agonists at atypical beta-adrenoreceptors
    Patent number: 7034053
    Abstract: The present invention disclosed compounds of Formula I. The present invention also discloses beta-3 agonists of formula I and methods for treating beta-3 mediated diseases and condition using the compounds of formula I, in particular methods for treating diabetes or obesity.
    Type: Grant
    Filed: December 17, 2001
    Date of Patent: April 25, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: David N. Deaton, Barry George Shearer, David Edward Uehling
  • Pyrrolidines as dipeptidyl peptidase inhibitors
    Publication number: 20040167341
    Abstract: The present invention relates to novel compounds of formula (I):, their use for inhibiting serine proteases, such as dipeptidyl peptidases, such as dipeptidyl peptidase IV (DPP-IV) and to methods for their production and their therapeutic utility.
    Type: Application
    Filed: December 19, 2003
    Publication date: August 26, 2004
    Inventors: Curt Dale Haffner, Darryl Lynn McDougald, Armarjit Sab Randhawa, Steven Michael Reister, David N Deaton, Martin James Lenhard
  • Chemical compounds
    Publication number: 20040106672
    Abstract: The present invention discloses compounds of Formula I. The present invention also discloses beta-3 agonists of formula I and methods for treating beta-3 mediated diseases and condition using the compounds of formula I, in particular methods for treating diabetes or obesity.
    Type: Application
    Filed: July 31, 2003
    Publication date: June 3, 2004
    Inventors: David N. Deaton, Barry George Shearer, David Edward Uehling